Treatment of MDR-TB using therapeutic drug monitoring: first experiences with sub-300 mg linezolid dosages using in-house made capsules

Mathieu S Bolhuis; Tjip S van der Werf; Huib A M Kerstjens; Wiel C M de Lange; Jan-Willem C Alffenaar; Onno W Akkerman

doi:10.1183/13993003.00580-2019

Publication

Treatment of MDR-TB using therapeutic drug monitoring: first experiences with sub-300 mg linezolid dosages using in-house made capsules

Bolhuis, M. S., van der Werf, T. S., Kerstjens, H. A. M., de Lange, W. C. M., Alffenaar, J-W. C. & Akkerman, O. W., 22-Aug-2019, In : European Respiratory Journal.

Research output: Contribution to journal › Article › Academic › peer-review

Overview
Citation formats

Handle.net

http://hdl.handle.net/11370/c54392e8-4abf-48c5-9f3b-a64590218782

Documents

Treatment of MDR-TB using therapeutic drug monitoring first experiences with sub-300 mg linezolid dosages using in-house made capsules
Final author's version, 448 KB, PDF document
Embargo ends: 28/08/2020
Request copy

DOI

https://doi.org/10.1183/13993003.00580-2019
Final publisher's version

Mathieu S Bolhuis
Tjip S van der Werf
Huib A M Kerstjens
Wiel C M de Lange
Jan-Willem C Alffenaar
Onno W Akkerman

Microbes in Health and Disease (MHD)
Groningen Research Institute for Asthma and COPD (GRIAC)

Original language	English
Journal	European Respiratory Journal
Publication status	E-pub ahead of print - 22-Aug-2019

View graph of relations

ID: 94909689

University of Groningen staff: edit these data